New cholesterol drug shows promise in indian patients
NCT ID NCT06386419
First seen Apr 25, 2026 · Last updated May 17, 2026 · Updated 8 times
Summary
This study looked at how safe and effective the drug inclisiran is for Indian adults with high cholesterol or mixed dyslipidemia. Sixty-five participants received the drug as a shot under the skin. Researchers tracked side effects and measured how much LDL (bad) cholesterol dropped over 300 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis Investigative Site
Bangalore, Karnataka, 560099, India
-
Novartis Investigative Site
Belagavi, Karnataka, 590010, India
-
Novartis Investigative Site
Mumbai, Maharashtra, 400012, India
-
Novartis Investigative Site
Nagpur, Maharashtra, 441108, India
-
Novartis Investigative Site
New Delhi, National Capital Territory of Delhi, 110029, India
-
Novartis Investigative Site
Jaipur, Rajasthan, 302039, India
-
Novartis Investigative Site
Madurai, Tamil Nadu, 625107, India
-
Novartis Investigative Site
Vellore, Tamil Nadu, 632 004, India
-
Novartis Investigative Site
Kolkata, West Bengal, 700 020, India
Conditions
Explore the condition pages connected to this study.